Theriva Biologics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2011
Total Assets: $7.5M
Liabilities Breakdown FY2011
Total Liabilities: $417.0K
Asset Breakdown
Total Assets: $7.5M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $6.7M | 89.3% |
| Accounts Receivable | $405.0K | 5.4% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $323.0K | 4.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $70.0K | 0.9% |
Liabilities Breakdown
Total Liabilities: $417.0K
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $388.0K | 93.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $29.0K | 7.0% |